Drug treatment of multiple sclerosis
Authors:
- 1 December 2000
- journal article
- Published by BMJ in Western Journal of Medicine
- Vol. 173 (6) , 398-402
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- A quantitative analysis of oligodendrocytes in multiple sclerosis lesionsBrain, 1999
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosisAnnals of Neurology, 1998
- New insights into the immunogenetics of multiple sclerosisCurrent Opinion in Neurology, 1997
- Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in PathogenesisBrain Pathology, 1996
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosisAnnals of Neurology, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosisAnnals of Neurology, 1995
- Overview of azathioprine treatment in multiple sclerosisThe Lancet, 1991